Roche has announced that Kenya will participate in a global clinical trial for potential treatment for COVID-19 associated pneumonia.
COVID-19 patients in Kenya have already began enrolling in the EMPACTA clinical trial at the Clinical Research Unit at the Aga Khan University Hospital, Nairobi.